Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 4.22 billion. The enterprise value is 10.51 billion.
Market Cap | 4.22B |
Enterprise Value | 10.51B |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | Mar 18, 2025 |
Share Statistics
Dexco has 808.36 million shares outstanding. The number of shares has decreased by -0.20% in one year.
Current Share Class | 808.36M |
Shares Outstanding | 808.36M |
Shares Change (YoY) | -0.20% |
Shares Change (QoQ) | -0.40% |
Owned by Insiders (%) | 33.60% |
Owned by Institutions (%) | 29.09% |
Float | 227.68M |
Valuation Ratios
The trailing PE ratio is 15.86 and the forward PE ratio is 9.06. Dexco's PEG ratio is 0.16.
PE Ratio | 15.86 |
Forward PE | 9.06 |
PS Ratio | 0.51 |
PB Ratio | 0.59 |
P/TBV Ratio | 0.70 |
P/FCF Ratio | n/a |
P/OCF Ratio | 3.40 |
PEG Ratio | 0.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of -11,182.84.
EV / Earnings | 39.50 |
EV / Sales | 1.28 |
EV / EBITDA | 6.47 |
EV / EBIT | 23.07 |
EV / FCF | -11,182.84 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.03.
Current Ratio | 1.37 |
Quick Ratio | 0.77 |
Debt / Equity | 1.03 |
Debt / EBITDA | 4.76 |
Debt / FCF | -7,810.77 |
Interest Coverage | 0.47 |
Financial Efficiency
Return on equity (ROE) is 3.94% and return on invested capital (ROIC) is 1.58%.
Return on Equity (ROE) | 3.94% |
Return on Assets (ROA) | 1.28% |
Return on Invested Capital (ROIC) | 1.58% |
Return on Capital Employed (ROCE) | 2.57% |
Revenue Per Employee | 576,413 |
Profits Per Employee | 18,705 |
Employee Count | 14,228 |
Asset Turnover | 0.45 |
Inventory Turnover | 3.94 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.41% in the last 52 weeks. The beta is 0.57, so Dexco's price volatility has been lower than the market average.
Beta (5Y) | 0.57 |
52-Week Price Change | -31.41% |
50-Day Moving Average | 5.50 |
200-Day Moving Average | 6.79 |
Relative Strength Index (RSI) | 43.47 |
Average Volume (20 Days) | 3,541,470 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.20 billion and earned 266.13 million in profits. Earnings per share was 0.33.
Revenue | 8.20B |
Gross Profit | 1.94B |
Operating Income | 372.33M |
Pretax Income | 357.26M |
Net Income | 266.13M |
EBITDA | 1.48B |
EBIT | 372.33M |
Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 1.12 billion in cash and 7.34 billion in debt, giving a net cash position of -6.06 billion or -7.50 per share.
Cash & Cash Equivalents | 1.12B |
Total Debt | 7.34B |
Net Cash | -6.06B |
Net Cash Per Share | -7.50 |
Equity (Book Value) | 7.11B |
Book Value Per Share | 8.50 |
Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was 1.24 billion and capital expenditures -1.24 billion, giving a free cash flow of -940,000.
Operating Cash Flow | 1.24B |
Capital Expenditures | -1.24B |
Free Cash Flow | -940,000 |
FCF Per Share | -0.00 |
Margins
Gross margin is 23.62%, with operating and profit margins of 4.54% and 3.25%.
Gross Margin | 23.62% |
Operating Margin | 4.54% |
Pretax Margin | 4.36% |
Profit Margin | 3.25% |
EBITDA Margin | 18.07% |
EBIT Margin | 4.54% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.12%.
Dividend Per Share | 0.22 |
Dividend Yield | 4.12% |
Dividend Growth (YoY) | -81.61% |
Years of Dividend Growth | n/a |
Payout Ratio | 87.87% |
Buyback Yield | 0.20% |
Shareholder Yield | 4.32% |
Earnings Yield | 6.31% |
FCF Yield | -0.02% |
Stock Splits
The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.
Last Split Date | Dec 21, 2022 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |